The novel, proteasome-independent NF-kappaB inhibitor V1810 induces apoptosis and cell cycle arrest in multiple myeloma and overcomes NF-kappaB-mediated drug resistance.

Source:http://linkedlifedata.com/resource/pubmed/id/20124446

Download in:

View as

General Info

PMID
20124446